Compounds > fluorouracil
Page last updated: 2024-10-27

fluorouracil and Carcinoma, Colloid

fluorouracil has been researched along with Carcinoma, Colloid in 185 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"Both regorafenib and reduced-intensity FOLFOXIRI (riFOLFOXIRI) prolong survival in patients with metastatic colorectal cancer (mCRC)."9.34Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer. ( Chang, SC; Chao, Y; Chen, WS; Cheng, HH; Huang, SC; Jiang, JK; Lan, YT; Lin, CC; Lin, HH; Tai, CC; Teng, HW; Wang, HS; Yang, SH, 2020)
"This multicenter, randomized trial compared overall response rate between pemetrexed plus irinotecan (ALIRI) and leucovorin-modulated 5-fluorouracil plus irinotecan (FOLFIRI) in patients with advanced colorectal cancer."9.12A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer. ( Bazin, IS; Biakhov, MY; Blatter, J; Goldstein, D; Gorbounova, VA; Granov, DA; Hossain, AM; Kaiser, C; Ma, D; Underhill, C, 2007)
"Mucinous colorectal cancer (CRC) exhibits distinct clinical and pathological features, including poorer response to fluorouracil (FU) compared with non-mucinous tumours."7.79Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. ( Ardizzoni, A; Azzoni, C; Bottarelli, L; Campanini, N; Cascinu, S; Cunningham, D; Mandolesi, A; Negri, FV; Scartozzi, M; Silini, EM; Tinelli, C; Wotherspoon, A, 2013)
"We conducted a retrospective analysis of prognosis factors for survival in breast cancer patients with 1-3 axillary lymph node metastases and tried to identify a subset of patients with good prognosis suitable for cyclophosphamide, methotrexate and 5-fluorouracil (CMF) adjuvant chemotherapy."7.73Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy. ( Chang, HK; Chen, MF; Chen, SC; Hsueh, S; Hwang, TL; Lin, YC; Lo, YF; Tsai, CS, 2005)
"The purpose of this study is to determine the characteristic clinical features, radiologic findings, and precipitating and prognostic factors in the patients with breast cancer and with 5-Fluorouracil (5-FU)-induced leukoencephalopathy."7.715-fluorouracil-induced leukoencephalopathy in patients with breast cancer. ( Cho, KH; Choi, SM; Kim, BC; Kim, MK; Lee, SH; Yang, YS, 2001)
"In this prospective randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma, patients did not derive clinical benefit from fluorouracil-based chemotherapy, given there were no objective responses, no difference in OS when treatment was delayed 6 months, and no difference in the rate of tumor growth while receiving chemotherapy."5.69Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial. ( Beaty, KA; Eng, C; Foo, WC; Fournier, K; Hornstein, N; Lano, E; Mansfield, P; Matamoros, A; Overman, MJ; Rafeeq, S; Raghav, KP; Scally, C; Scofield, LC; Shen, JP; Taggart, M; Tidwell, RS; Uppal, A; Yousef, AM; Zeineddine, FA; Zeineddine, MA, 2023)
"Capecitabine (CA) is an orally administered fluoropyrimidine carbamate which is preferentially converted to active 5-FU and is one of the agents used instead of FU in such cases."5.39Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma? ( Isikli, L; Yoney, A, 2013)
"Both regorafenib and reduced-intensity FOLFOXIRI (riFOLFOXIRI) prolong survival in patients with metastatic colorectal cancer (mCRC)."5.34Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer. ( Chang, SC; Chao, Y; Chen, WS; Cheng, HH; Huang, SC; Jiang, JK; Lan, YT; Lin, CC; Lin, HH; Tai, CC; Teng, HW; Wang, HS; Yang, SH, 2020)
"This multicenter, randomized trial compared overall response rate between pemetrexed plus irinotecan (ALIRI) and leucovorin-modulated 5-fluorouracil plus irinotecan (FOLFIRI) in patients with advanced colorectal cancer."5.12A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer. ( Bazin, IS; Biakhov, MY; Blatter, J; Goldstein, D; Gorbounova, VA; Granov, DA; Hossain, AM; Kaiser, C; Ma, D; Underhill, C, 2007)
"Fifty-seven evaluable patients with advanced ovarian carcinoma were randomized to receive either a combination of hexamethylmelamine, cyclophosphamide, methotrexate and 5-fluorouracil (Hexa-CAF) or high-dose cyclophosphamide alone given intravenously intermittently."5.05Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF). ( Carmo-Pereira, J; Costa, FO; Henriques, E; Ricardo, JA, 1981)
"There have been controversies in prognostic impact of mucinous histology on colorectal cancer, and its implication in patients treated with adjuvant 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) is unclear."3.79Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy. ( Bae, JM; Bang, YJ; Cho, NY; Han, SW; Im, SA; Jeong, SY; Kang, GH; Kim, TY; Lee, DW; Lee, HJ; Lee, KH; Oh, DY; Park, JG; Park, KJ; Rhee, YY, 2013)
"Mucinous colorectal cancer (CRC) exhibits distinct clinical and pathological features, including poorer response to fluorouracil (FU) compared with non-mucinous tumours."3.79Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. ( Ardizzoni, A; Azzoni, C; Bottarelli, L; Campanini, N; Cascinu, S; Cunningham, D; Mandolesi, A; Negri, FV; Scartozzi, M; Silini, EM; Tinelli, C; Wotherspoon, A, 2013)
"The prognostic impact of CpG island methylator phenotype (CIMP) and microsatellite instability (MSI) on the treatment outcome of colon cancer patients receiving adjuvant 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX) is unclear."3.79Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer. ( Bae, JM; Bang, YJ; Cho, NY; Han, SW; Im, SA; Jeong, SY; Kang, GH; Kim, TY; Lee, HJ; Lee, KH; Oh, DY; Park, JG; Park, KJ, 2013)
"The patients with local advanced and metastatic colorectal cancer, receiving fluorouracil-based chemotherapy, and with an average plasma concentration of fluorouracil between 25 - 35 mg/L have a better prognosis, and lower incidence of adverse reactions such as bone marrow suppression, mucositis and diarrhea."3.78[Role of pharmacokinetic monitoring of serum fluorouracil concentration in patients with local advanced and metastatic colorectal cancer and further improving efficacy of fluorouracil-based chemotherapy]. ( Cai, X; Gu, HL; Hu, J; Song, WF; Wang, LW; Xue, P; Yang, HY, 2012)
"The aim of this study was to determine whether the relative mRNA expressions of the thymidylate synthase (TYMS) and the excision repair cross-complementing 1 (ERCC1) genes are associated with in vitro chemosensitivity to 5-fluorouracil (5-FU) and oxaliplatin in colorectal cancer, respectively."3.77Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer. ( Cho, YB; Choi, SH; Chun, HK; Chung, HJ; Kim, HC; Lee, WY; Yun, SH, 2011)
"We conducted a retrospective analysis of prognosis factors for survival in breast cancer patients with 1-3 axillary lymph node metastases and tried to identify a subset of patients with good prognosis suitable for cyclophosphamide, methotrexate and 5-fluorouracil (CMF) adjuvant chemotherapy."3.73Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy. ( Chang, HK; Chen, MF; Chen, SC; Hsueh, S; Hwang, TL; Lin, YC; Lo, YF; Tsai, CS, 2005)
"The purpose of this study is to determine the characteristic clinical features, radiologic findings, and precipitating and prognostic factors in the patients with breast cancer and with 5-Fluorouracil (5-FU)-induced leukoencephalopathy."3.715-fluorouracil-induced leukoencephalopathy in patients with breast cancer. ( Cho, KH; Choi, SM; Kim, BC; Kim, MK; Lee, SH; Yang, YS, 2001)
"Sequential therapy consisting of methotrexate (MTX) and 5-FU was performed together with the administration of heparin and FOY in 10 cases of gastric cancer with disseminated intravascular coagulation (DIC) causing systemic bone metastasis."3.68[Sequential MTX and 5-FU therapy of gastric cancer with systemic bone metastasis and disseminated intravascular coagulation]. ( Ibuka, T; Imai, K; Ishiwata, J; Kobayashi, T; Monma, K; Ohno, T; Onozawa, Y; Sakaki, N; Sasaki, T; Tabata, I, 1992)
"We consider that our observations in gastric cancer patients in our clinic can be useful in the future randomised trials to point the way to improved outcomes."2.79Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution. ( Coskun-Breuneval, M; Demirkasimoglu, T; Elgin, Y; Guney, Y; Kara, SP; Kucukpilakci, B; Misirlioglu, HC; Ozgen, A; Sanri, E; Ugur, VI, 2014)
"(SD 1."2.78Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution. ( Khemapech, N; Oranratanaphan, S, 2013)
"Gastric cancer is the second most common among cancer-related deaths in the world."2.77Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution. ( Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M, 2012)
"Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis (PC) as the only site of metastases."2.77The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. ( Bertrand, C; Ceelen, W; D'Hoore, A; Fieuws, S; Hompes, D; Kerger, J; Legendre, H; Peeters, M; Van Cutsem, E; Van der Speeten, K, 2012)
" This study was to investigate the efficacy and safety of oxaliplatin in combination with capecitabine as first-line chemotherapy for AGC patients."2.74[Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer]. ( Dong, NN; Liu, ZF; Wang, MY; Zhang, Q, 2009)
"Patients with rectal cancer of stage dukes B and C were randomized into two groups."2.68[Preoperative intraluminal 5-FU osmosis chemotherapy as an adjuvant to radical resection for rectal cancer]. ( Liu, L; Lu, J; Zhao, L, 1996)
"There were 51 patients with colorectal cancer and 130 patients with appendiceal cancer."2.68Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. ( Jablonski, KA; Sugarbaker, PH, 1995)
"Twenty patients with non-resectable rectal cancer (Mason CS III-IV) have been irradiated from September 1989 through February 1994."2.68[Preoperative radiochemotherapy in primary non-resectable rectal cancer]. ( Dunst, J; Dworak, O; Keilholz, L; Köckerling, F; Sauer, R; Schwarz, B, 1995)
"We studied how gastric cancer tissues and cells changed as a result of preoperative chemotherapy."2.68[Influence of preoperative on gastric cancer tissues and cells]. ( Chen, Z; Li, G; Liu, F, 1997)
"Eighty-two patients with colo-rectal cancers (29 colon and 53 rectum) were admitted and underwent radical resection from January 1982 to June 1984."2.66[Reevaluation of intraluminal fluorouracil chemotherapy as an adjuvant to radical resection of colorectal cancer--results of a randomized trial]. ( Wan, DS, 1988)
"Intussusception is relatively rare in adults, particularly in portions of the colon fixed to the retroperitoneum, such as the descending colon."2.53[A Case of Intussusception Caused by Descending Colon Cancer]. ( Hashimoto, Y; Hotta, S; Iwaki, T; Kameyama, H; Kobayashi, T; Oyamatsu, M; Sakata, J; Sato, K; Sato, Y; Shimada, Y; Wakai, T, 2016)
"In metastatic colorectal cancer (MCRC), mucinous histology has been associated with poor response rate and prognosis."1.56Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients. ( Alessandroni, P; Bergamo, F; Borelli, B; Catalano, V; Cremolini, C; Falcone, A; Giordani, P; Graziano, F; Intini, R; Lonardi, S; Mattioli, R; Negri, F; Rocchi, MBL; Rossini, D; Santini, D; Sarti, D; Stragliotto, S; Vincenzi, B; Zagonel, V, 2020)
"Patients with PM from colorectal cancer and PCI >20 that were treated with CRS and HIPEC experience a one year longer and doubled overall survival compared with open-close/debulking patients."1.56Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. ( Artursson, S; Birgisson, H; Cashin, P; Enblad, M; Ghanipour, L; Graf, W, 2020)
"No recurrent inguinal hernias were recorded and no patients required an inguinal incision at a later time to resect progressive disease within the inguinal canal."1.46Management of an inguinal hernia in patients with pseudomyxoma peritonei. ( Sugarbaker, PH, 2017)
"A total of 196 stage II and III colon cancer patients were retrospectively enrolled in prospectively collected data."1.42T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy. ( An, MS; Bae, KB; Choi, CS; Hong, KH; Hwang, JW; Kang, MS; Kim, BM; Kim, JH; Kim, KH; Oh, MK; Yoo, JH, 2015)
"MC was found in 12."1.39Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. ( de Hingh, IH; de Wilt, JH; Hugen, N; Lemmens, VE; Nagtegaal, ID; Pruijt, JF; Radema, SA; Verhoeven, RH, 2013)
"Capecitabine (CA) is an orally administered fluoropyrimidine carbamate which is preferentially converted to active 5-FU and is one of the agents used instead of FU in such cases."1.39Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma? ( Isikli, L; Yoney, A, 2013)
" FOLFOX4 combined with panitumumab therapy was initiated 1 month after the operation."1.38[A case report of advanced mucinous adenocarcinoma of the transverse colon with peritoneal dissemination effectively treated by multidisciplinary approach with a focus on FOLFOX4 therapy combined with panitumumab]. ( Asano, T; Hattori, M; Kamiya, I; Negita, M; Takagi, D; Uemura, T, 2012)
"Patients with resected pancreatic cancer (PC) have a poor prognosis."1.38Real-world impact of availability of adjuvant therapy on outcomes in patients with resected pancreatic adenocarcinoma: a Canadian Cancer Agency experience. ( Gill, S; Kim, C; Owen, D, 2012)
"Carcinomas were categorized by MRI as mucinous (mucin proportion >50% within the tumor volume), and as nonmucinous."1.38Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. ( Düber, C; Hansen, T; Heintz, A; Hötker, AM; Junginger, T; Kreft, A; Kreitner, KF; Menig, M; Oberholzer, K; Schmidberger, H; Schneider, A, 2012)
"The majority of patients with gastric cancer in developing countries present with advanced disease."1.38Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study. ( Guven, M; Inal, A; Işikdogan, A; Kaplan, MA; Kuçukoner, M; Nas, N; Urakci, Z; Yunce, M, 2012)
"Patients with mucinous rectal cancer experienced a lower rate of T-downstaging after PCRT and had a poorer prognosis than did patients with nonmucinous cancer."1.37Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. ( Kim, CW; Kim, JC; Kim, JH; Kim, TW; Lim, SB; Shin, US; Yoon, SN; Yoon, YS; Yu, CS, 2011)
"We studied 26 gastric cancer patients with lymph node metastasis who underwent gastric resection at the Korea University Guro Hospital from Feb 2007 to July 2008."1.37Metastatic lymph node targeted chemosensitivity test for gastric cancer. ( Jang, YJ; Kim, CS; Kim, JH; Kim, SJ; Mok, YJ; Park, SH; Park, SS, 2011)
"Eighty five patients with advanced gastric cancer accepted oxaliplatin/5-FU-based chemotherapy as first-line chemotherapy were investigated."1.36[Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy]. ( Jiang, J; Jiang, T; Li, QF; Liang, J; Lü, HY; Song, SA; Sun, YY; Yao, RY, 2010)
"104 patients with advanced gastric cancers were treated with capecitabine-based chemotherapy regimens from Sept."1.35[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer]. ( Li, J; Li, Y; Lu, M; Shen, L; Xiao, Y; Zhang, J; Zhang, XD, 2009)
"A treatment of 5-fluorouracil (500 mg/body) with l-leucovorin (100 mg/body) intravenously once a week, or oral S-1 (100 mg/day/body) for four weeks, was given during radiation therapy."1.35[Assessment of chemoradiation therapy for advanced rectal cancer invaded the pelvic organ]. ( Doi, K; Hirano, Y; Ishihara, A; Kojima, K; Kudo, K; Ochi, T; Ogata, K, 2009)
"Rectovaginal fistula in long-standing Crohn's disease is possibly associated with malignant transformation to mucinous adenocarcinoma of the vagina."1.35Vulvar mucinous adenocarcinoma associated with Crohn's disease: report of two cases. ( Chi, DS; Eno, ML; Im, DD; Matsuo, K; Rosenshein, NB, 2009)
"Fresh samples of gastric cancer obtained from operation room were prepared to single-cell suspension (3 x 10(5) to 5 x 10(5) cells ml(-1)) and were separately exposed to taxol (TAX), cisplatin (CDDP), 5-fluorouracil (5-Fu), adriamycin (ADM), mitomycin (MMC) for 48 hours."1.34[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA]. ( Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Wang, XY; Yin, YC, 2007)
"The type of genomic instability could influence the prognosis of CRC, in particular in stages II and III."1.33Microsatellite instability and colorectal cancer prognosis. ( Barana, D; Benatti, P; Di Gregorio, C; Gafà, R; Guerzoni, L; Lanza, G; Losi, L; Maestri, I; Maffei, S; Marino, M; Menigatti, M; Oliani, C; Pedroni, M; Ponti, G; Ponz de Leon, M; Roncari, B; Roncucci, L; Rossi, G; Santini, A; Scarselli, A, 2005)
"Mucinous carcinoma was diagnosed by core needle biopsy (T2: 5 cm N1 M0)."1.33A case of mucinous carcinoma of the breast that demonstrated a good pathological response to neoadjuvant chemotherapy despite a poor clinical response. ( Akashi-Tanaka, S; Fukutomi, T; Iwamoto, E; Kinosita, T; Takasugi, M; Yamaguchi, J, 2006)
"We present a male patient with a perianal fistula of 30 years' duration that had been treated on several occasions."1.33[Mucinous adenocarcinoma on chronic perianal fistula treated by neoadjuvant chemoradiotherapy and laparoscopy-assisted abdominoperineal amputation]. ( Almendral, ML; Aranda, F; Echenique-Elizondo, M; Erro, JM; Ibáñez, J; Valenti, C, 2006)
"Patients with mucinous colorectal cancer generally have worse prognoses than those with the nonmucinous variety."1.33Unfavourable expression of pharmacologic markers in mucinous colorectal cancer. ( Carvalho, LP; Fleshman, JW; Glasgow, SC; McLeod, HL; Shannon, WD; Yu, J, 2005)
" Pharmacokinetic studies after administration of S-1 revealed high and prolonged plasma 5-FU levels."1.32S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study. ( Ajani, JA; Itoh, N; Itoi, H; Shirasaka, T; Ueda, Y; Yamagishi, H; Yamashita, T, 2004)
"Breast cancer has a significant capacity to metastasize to bone."1.32Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid. ( Bielawski, KP; Bosse, U; Schlotter, CM; Vogt, U, 2004)
"Leser-Trélat-syndrome is characterized as the eruptive appearance of multiple seborrheic keratoses in association with underlying malignant disease."1.31[Clinical and histopathological characteristics of early Leser-Trélat syndrome]. ( Barth, G; Basten, O; Rompel, R; Rüschoff, J, 2001)
"The outcome of patients with mucinous appendiceal neoplasms with peritoneal surface dissemination has changed as a result of a better understanding of the clinical and pathologic features of this disease."1.31Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. ( Esquivel, J; Sugarbaker, PH, 2001)
"Patients with primary rectal cancer deemed eligible for preoperative radiation and 5-fluorouracil-based chemotherapy because of a clinically bulky or tethered tumor or endorectal ultrasound evidence of T3 and/or N1 were prospectively enrolled."1.31Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. ( Akhurst, T; Cohen, AM; Erdi, Y; Finn, RD; Gollub, MJ; Guillem, JG; Humm, J; Klimstra, DS; Larson, S; Macapinlac, H; Mazumdar, M; Minsky, BD; Paty, PB; Puig-La Calle, J; Ruo, L; Saltz, L; Tickoo, S; Yeung, H, 2000)
"Three cases of postoperative gastric cancer with peritoneal dissemination were treated by combined administration of CDDP, 5-FU and Lentinan."1.29[Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan]. ( Mio, H; Terabe, K, 1994)
"Thirty patients with advanced colorectal cancer were treated preoperatively by combined regional radiofrequency hyperthermia and 5-FU."1.28[Preoperative regional radiofrequency thermochemotherapy of colorectal cancer: clinical and pathological studies]. ( Wu, GR, 1992)
"Pseudomyxoma peritonei is an unusual malignancy arising from the goblet cells of the large bowel or appendix."1.27Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment. ( Kern, K; Lack, E; Sugarbaker, PH, 1987)
"The chemosensitivity of human colorectal cancer was studied in relation to the biological features of the tumor using a human tumor/nude mouse in-vivo system."1.27Biological features and chemosensitivity of human colorectal cancer xenografted in nude mice. ( Yamada, K, 1987)
"For the response of advanced gastric cancer to chemotherapy in the National Cancer Center Hospital, the combined use of UFT and Mitomycin C gave the highest rate, 46%."1.27Radiation therapy for advanced gastric cancer. ( Akine, Y; Egawa, S; Hijikata, J; Kajiura, Y; Kitagawa, T; Ogino, T; Tsukiyama, I; Yamashita, K, 1988)
"A metastatic renal cell carcinoma was found on the pelvic peritoneum and characteristic renal cancer cells were identified in the ascitic fluid."1.27[Synchronous double cancers in the ovary and kidney--a case report]. ( Fujiwara, A; Katsube, Y; Myoga, H; Nogawa, T; Ohta, S; Shigemasa, K; Shinko, Y; Tamaki, M, 1988)
"She died from general metastasis seven months after the radical mastectomy in spite of adjuvant immunochemotherapy."1.27[A case of bilateral metastatic breast carcinoma from gastric carcinoma]. ( Hanamura, N; Iida, F; Kasuga, Y; Katsuyama, T; Oota, H; Senga, O; Tsuchiya, S, 1986)

Research

Studies (185)

TimeframeStudies, this research(%)All Research%
pre-199046 (24.86)18.7374
1990's18 (9.73)18.2507
2000's53 (28.65)29.6817
2010's60 (32.43)24.3611
2020's8 (4.32)2.80

Authors

AuthorsStudies
Kadono, T1
Okuyama, Y2
Nakatsugawa, Y1
Yamada, S2
Nishimura, T1
Fujii, H1
Tomatsuri, N1
Sato, H1
Kimura, H1
Urata, Y1
Shen, JP1
Yousef, AM1
Zeineddine, FA1
Zeineddine, MA1
Tidwell, RS1
Beaty, KA1
Scofield, LC1
Rafeeq, S2
Hornstein, N1
Lano, E1
Eng, C2
Matamoros, A1
Foo, WC1
Uppal, A1
Scally, C1
Mansfield, P1
Taggart, M1
Raghav, KP1
Overman, MJ2
Fournier, K1
Catalano, V1
Bergamo, F1
Cremolini, C1
Vincenzi, B1
Negri, F1
Giordani, P1
Alessandroni, P1
Intini, R1
Stragliotto, S1
Rossini, D1
Borelli, B1
Santini, D1
Sarti, D1
Rocchi, MBL1
Lonardi, S1
Falcone, A1
Zagonel, V1
Mattioli, R2
Graziano, F1
Tai, CC1
Chen, WS1
Jiang, JK1
Yang, SH1
Wang, HS1
Chang, SC1
Lan, YT1
Lin, CC1
Lin, HH1
Huang, SC1
Cheng, HH1
Chao, Y1
Teng, HW1
Kolla, BC1
Petersen, A1
Chengappa, M1
Gummadi, T1
Ganesan, C1
Gaertner, WB1
Blaes, A1
Taibi, A1
Lo Dico, R1
Kaci, R1
Naneix, AL1
Mathonnet, M1
Pocard, M2
Birgisson, H1
Enblad, M1
Artursson, S1
Ghanipour, L1
Cashin, P1
Graf, W1
Kosmala, R1
Fokas, E1
Flentje, M1
Sauer, R3
Liersch, T2
Graeven, U1
Fietkau, R2
Hohenberger, W2
Arnold, D1
Hofheinz, RD1
Ghadimi, M1
Ströbel, P1
Staib, L1
Grabenbauer, GG1
Folprecht, G1
Kirste, S1
Uter, W1
Gall, C1
Rödel, C2
Polat, B1
Mayanagi, S1
Kashiwabara, K1
Honda, M1
Oba, K2
Aoyama, T1
Kanda, M1
Maeda, H1
Hamada, C1
Sadahiro, S1
Sakamoto, J2
Saji, S1
Yoshikawa, T1
Greally, M1
Pilson, K1
Linehan, A1
O'Keane, C1
Shields, CJ1
Conneely, JB1
McCaffrey, JA1
Rombouts, AJM1
Hugen, N2
Verhoeven, RHA1
Elferink, MAG1
Poortmans, PMP1
Nagtegaal, ID3
de Wilt, JHW1
Takada, S1
Sagawa, T1
Fujikawa, K1
Tahatsu, K1
Fukai, Y1
Hashishita, H1
Takahashi, Y1
Endo, M1
Lee, DW3
Han, SW4
Cha, Y1
Bae, JM4
Kim, HP1
Lyu, J1
Han, H1
Kim, H2
Jang, H1
Bang, D1
Won, JK1
Jeong, SY4
Park, KJ4
Kang, GH4
Kim, TY8
Yokoyama, T1
Makino, H1
Hirakata, A1
Ueda, J1
Takata, H1
Okusa, M1
Kawashima, M1
Tsujino, T1
Hosone, M1
Matsushita, A1
Nakamura, Y1
Yoshida, H1
Wang, L3
Li, PF1
Geng, M2
Cao, YC2
Yin, YC2
Lee, HJ3
Rhee, YY2
Cho, NY3
Lee, KH3
Oh, DY4
Im, SA4
Bang, YJ4
Park, JG3
Cai, Z1
Ke, J1
He, X1
Yuan, R1
Chen, Y1
Wu, X2
Wang, J1
Lan, P1
Kim, SH2
Shin, SJ1
Lee, KY1
Kim, TI1
Kang, DR1
Hur, H2
Min, BS1
Kim, NK1
Chung, HC1
Roh, JK1
Ahn, JB1
Yamazaki, K1
Katsumura, N1
Ozawa, N1
Ogiso, H1
Hanai, Y1
Otsuji, K1
Toda, K1
Morino, K1
Mori, Y1
Araki, H1
Moriwaki, H1
Verhoeven, RH1
Radema, SA1
de Hingh, IH1
Pruijt, JF1
Lemmens, VE1
de Wilt, JH1
Oranratanaphan, S1
Khemapech, N1
Negri, FV2
Azzoni, C1
Bottarelli, L1
Campanini, N1
Mandolesi, A1
Wotherspoon, A2
Cunningham, D2
Scartozzi, M1
Cascinu, S2
Tinelli, C1
Silini, EM1
Ardizzoni, A1
Yoney, A1
Isikli, L1
Toiyama, Y1
Inoue, Y1
Saigusa, S1
Kawamura, M1
Kawamoto, A1
Okugawa, Y1
Hiro, J1
Tanaka, K1
Mohri, Y1
Kusunoki, M1
Wu, H1
He, YL1
Xu, JB1
Cai, SR1
Ma, JP1
Chen, CQ1
Zhang, XH1
Zhan, WH1
Hirata, K1
Nagata, N1
Kato, T1
Andoh, H1
Takahashi, K1
Hazama, S1
Mishima, H1
Kim, KJ1
Swellengrebel, HA1
Bosch, SL1
Cats, A1
Vincent, AD1
Dewit, LG1
Verwaal, VJ1
Marijnen, CA1
Kaytan Saglam, E1
Yucel, S1
Balik, E1
Saglam, S1
Asoglu, O1
Yamaner, S1
Bugra, D1
Oral, EN1
Kizir, A1
Kapran, Y1
Sakar, B1
Akyuz, A1
Gulluoglu, M1
Misirlioglu, HC1
Coskun-Breuneval, M1
Kucukpilakci, B1
Ugur, VI1
Elgin, Y1
Demirkasimoglu, T1
Kara, SP1
Ozgen, A1
Sanri, E1
Guney, Y1
Choe, JH1
Fournier, KF1
Royal, RE1
Ohinata, A1
Beaty, K1
Phillips, JK1
Wolff, RA1
Mansfield, PF1
Milovanov, V1
Sardi, A1
Ledakis, P1
Aydin, N1
Nieroda, C1
Sittig, M1
Nunez, M1
Gushchin, V2
An, MS1
Yoo, JH1
Kim, KH1
Bae, KB1
Choi, CS1
Hwang, JW1
Kim, JH4
Kim, BM1
Kang, MS1
Oh, MK1
Hong, KH1
Lam, JY1
McConnell, YJ1
Rivard, JD1
Temple, WJ1
Mack, LA1
Bibeau, F1
Berk, V1
Deniz, K1
Bozkurt, O1
Ozaslan, E1
Karaca, H1
Inanc, M1
Duran, AO1
Ozkan, M1
Vernmark, K1
Albertsson, M1
Björnsson, B1
Gasslander, T1
Sandström, P1
Sun, XF1
Holmqvist, A1
de Oliveira, SF1
Ganzinelli, M1
Chilà, R1
Serino, L1
Maciel, ME1
Urban, Cde A1
de Lima, RS1
Cavalli, IJ1
Generali, D1
Broggini, M1
Damia, G1
Ribeiro, EM1
Park, BS1
Kim, HS1
Sugarbaker, PH11
Hotta, S1
Kameyama, H1
Sato, K2
Oyamatsu, M1
Hashimoto, Y1
Sato, Y1
Iwaki, T1
Shimada, Y1
Sakata, J1
Kobayashi, T2
Wakai, T1
Tonooka, T1
Takiguchi, N1
Yamamoto, H1
Nabeya, Y1
Ikeda, A1
Kainuma, O1
Soda, H1
Imanishi, S1
Arimitsu, H1
Kobayashi, R1
Chibana, T1
Ishige, F1
Nagata, M1
Farquharson, AL1
Pranesh, N1
Witham, G1
Swindell, R1
Taylor, MB1
Renehan, AG1
Rout, S1
Wilson, MS1
O'Dwyer, ST1
Saunders, MP1
To, AC1
Looi, KL1
Damianovich, D1
Taylor, GB1
Sidebotham, D1
White, HD1
Wang, ZH1
Guo, J1
Chen, Z2
Li, CZ1
Sheng, LJ1
Zhou, DG1
Liu, B1
Liu, J1
Wang, QC1
Zhang, EN1
Chen, CF1
Huang, CJ1
Kang, WY1
Hsieh, JS1
Sato, S2
Itamochi, H1
Kigawa, J1
Oishi, T1
Shimada, M1
Naniwa, J1
Uegaki, K1
Nonaka, M1
Terakawa, N1
Koopman, M1
Kortman, GA1
Mekenkamp, L1
Ligtenberg, MJ1
Hoogerbrugge, N1
Antonini, NF1
Punt, CJ1
van Krieken, JH1
Gold, DG1
Miller, RC2
Haddock, MG2
Gunderson, LL2
Quevedo, F1
Donohue, JH2
Bhatia, S1
Nagorney, DM1
Schomas, DA1
Gill, S2
Thurmes, PJ1
Quevedo, JF1
Sideris, L2
Mitchell, A1
Drolet, P1
Leblanc, G1
Leclerc, YE1
Dubé, P1
Zhang, J1
Xiao, Y1
Lu, M1
Li, J1
Zhang, XD1
Li, Y1
Shen, L1
Dong, NN1
Wang, MY1
Zhang, Q2
Liu, ZF1
Qiu, MZ1
Teng, KY1
Ruan, DY1
Li, YH2
Chen, XQ1
Pan, ZZ1
He, YJ2
Wan, DS2
Xu, RH2
Swartz, MJ1
Hsu, CC1
Pawlik, TM1
Winter, J1
Hruban, RH1
Guler, M1
Schulick, RD1
Cameron, JL1
Laheru, DA1
Wolfgang, CL1
Herman, JM1
Palmirotta, R1
Savonarola, A1
Formica, V1
Ludovici, G1
Del Monte, G1
Roselli, M1
Guadagni, F1
Matsuo, K1
Chi, DS1
Eno, ML1
Im, DD1
Rosenshein, NB1
Masellis, AM1
Sielaff, TD1
Bender, GP1
Kadikoylu, G1
Barutca, S1
Tataroglu, C1
Kafkas, S1
Erpek, H1
Meydan, N1
Yavasoglu, I1
Bolaman, Z1
Doi, K1
Ogata, K1
Hirano, Y1
Kudo, K1
Ochi, T1
Ishihara, A1
Kojima, K1
Zhao, Y1
An, X1
Xiang, XJ1
Feng, F1
Wang, FH1
Wang, ZQ1
Shibaki, T1
Morimoto, N1
Bijelic, L2
Chang, D3
Yoo, D1
Jang, YJ1
Park, SS1
Park, SH1
Kim, SJ1
Kim, CS1
Mok, YJ1
Liang, J1
Li, QF1
Yao, RY1
Lü, HY1
Jiang, J1
Sun, YY1
Song, SA1
Jiang, T1
Lin, L1
Xu, JM1
Wang, Y1
Ge, FJ1
Liu, LJ1
Zhao, CH1
Li, SS1
Liu, JZ1
Li, ZQ1
Oberholzer, K1
Menig, M1
Kreft, A1
Schneider, A1
Junginger, T1
Heintz, A1
Kreitner, KF1
Hötker, AM1
Hansen, T1
Düber, C1
Schmidberger, H1
Shin, US1
Yu, CS1
Kim, TW1
Lim, SB1
Yoon, SN1
Yoon, YS1
Kim, CW1
Kim, JC1
Kim, C1
Owen, D1
Hirowatari, H2
Karasawa, K2
Izawa, H2
Ito, K2
Sasai, K1
Furuya, T2
Ozawa, S2
Arakawa, A1
Orihata, G1
Saito, M2
Kim, K1
Chie, EK1
Jang, JY1
Kim, SW1
Ha, SW1
Tatli, AM1
Uysal, M1
Goksu, SS1
Arslan, D1
Gunduz, S1
Ozdogan, M1
Coskun, HS1
Bozcuk, H1
Savas, B1
Cho, YB1
Chung, HJ1
Lee, WY1
Choi, SH1
Kim, HC1
Yun, SH1
Chun, HK1
Inal, A2
Kaplan, MA2
Kucukoner, M2
Isikdogan, A2
Suzuki, T1
Mitsuhashi, N1
Hompes, D1
D'Hoore, A1
Van Cutsem, E1
Fieuws, S1
Ceelen, W1
Peeters, M1
Van der Speeten, K1
Bertrand, C1
Legendre, H1
Kerger, J1
Cai, X1
Xue, P1
Song, WF1
Hu, J1
Gu, HL1
Yang, HY1
Wang, LW1
Peled, Y1
Levavi, H1
Krissi, H1
Weill, Y1
Sabah, G1
Eitan, R1
Asano, T1
Negita, M1
Uemura, T1
Takagi, D1
Hattori, M1
Kamiya, I1
Maisano, R1
Azzarello, D1
Maisano, M1
Mafodda, A1
Bottari, M1
Egitto, G1
Nardi, M1
Urakci, Z1
Guven, M1
Nas, N1
Yunce, M1
Xuan, Y1
Kim, YB1
Lee, G1
Shim, W1
Yun, J1
Ham, IH1
Han, SU1
Liang, JW1
Wang, Z1
Zhou, ZX1
Zhang, XM1
Hu, JJ1
Zhao, P1
Brunetti, G1
Delmastro, M1
Poggi, G1
Avanza, F1
Bertoli, G1
Kempin, S1
Gutierrez, J1
Wilson, E1
Lowery, C1
Diasio, R1
Akbulut, H1
Altuntas, F1
Akbulut, KG1
Ozturk, G1
Cindoruk, M1
Unal, E1
Icli, F1
Mohamed, F1
Peoples, GE1
Arciero, C1
Shriver, CD1
Levitz, JS1
Lichtman, SM1
Brun, EA1
Mai, KT1
Carnat, T1
Ueda, Y1
Yamagishi, H1
Yamashita, T1
Itoh, N1
Itoi, H1
Shirasaka, T1
Ajani, JA1
Vogt, U1
Bielawski, KP1
Bosse, U1
Schlotter, CM1
Glasgow, SC1
Yu, J1
Carvalho, LP1
Shannon, WD1
Fleshman, JW1
McLeod, HL1
Norman, AR1
Chong, G1
Ross, PJ1
Liberale, G1
Elias, D1
Lasser, P1
Malka, D1
Sabourin, JC1
Lin, YC1
Chen, SC1
Chang, HK1
Hsueh, S1
Tsai, CS1
Lo, YF1
Hwang, TL1
Chen, MF1
Martus, P1
Papadoupolos, T1
Füzesi, L1
Klimpfinger, M1
Raab, R1
Wittekind, C1
Benatti, P1
Gafà, R1
Barana, D1
Marino, M1
Scarselli, A1
Pedroni, M1
Maestri, I1
Guerzoni, L1
Roncucci, L1
Menigatti, M1
Roncari, B1
Maffei, S1
Rossi, G1
Ponti, G1
Santini, A1
Losi, L1
Di Gregorio, C1
Oliani, C1
Ponz de Leon, M1
Lanza, G1
Yamaguchi, J1
Akashi-Tanaka, S1
Fukutomi, T1
Kinosita, T1
Iwamoto, E1
Takasugi, M1
Alderman, R1
Edwards, G1
Marquardt, CE1
Esquivel, J2
Ibáñez, J1
Erro, JM1
Aranda, F1
Almendral, ML1
Valenti, C1
Echenique-Elizondo, M1
Zhang, YS1
Zhu, LF1
Weng, XS1
Yan, TD2
Links, M1
Xu, ZY1
Kam, PC1
Glenn, D1
Morris, DL1
Ohi, S1
Takahashi, N1
Hashimoto, H1
Tachibana, T1
Hirabayashi, T1
Sugiyama, K1
Yanaga, K1
Ishikawa, H1
Nio, Y1
Toga, T1
Maruyama, R1
Fukushima, M1
Avninder, S1
Bhatnagar, A1
Agrawal, U1
Saxena, S1
Grillo-Ruggieri, F1
Mantello, G1
Berardi, R1
Cardinali, M1
Fenu, F1
Iovini, G1
Montisci, M1
Fabbietti, L1
Marmorale, C1
Guerrieri, M1
Saba, V1
Bearzi, I1
Bonsignori, M1
Morris, M1
Platell, C1
Iacopetta, B1
Underhill, C1
Goldstein, D2
Gorbounova, VA1
Biakhov, MY1
Bazin, IS1
Granov, DA1
Hossain, AM1
Blatter, J1
Kaiser, C1
Ma, D1
Fu, ZJ1
Wang, XY1
Tai, YH1
Szepesi, T1
Szalay, S1
Breitenecker, G1
Schratter-Sehn, A1
Rogan, AM1
Riss, T1
Wittich, G1
Heckenthaler, W1
Fasching, W1
Scheiber, V1
Carmo-Pereira, J1
Costa, FO1
Henriques, E1
Ricardo, JA1
Benedetti Panici, P1
Di Roberto, P1
Margariti, PA1
Villani, L1
Sacco, F1
Cognetti, F1
Bompiani, A1
Okada, K3
Kitade, F1
Kawashima, Y1
Sakuramoto, K1
Okajima, K1
Abitbol, A1
Straus, MJ1
Sedlis, A1
Davidian, M1
Willie, GR1
Levy, SM1
Michaels, RS1
Zirkin, RM1
Kopper, L1
Magyarosy, E1
Jeney, A1
Lapis, K1
Szabolcs, A1
Otvös, L1
Jablonski, KA1
Keilholz, L1
Dworak, O1
Dunst, J1
Köckerling, F1
Schwarz, B1
Remmenga, SW1
Colcher, D1
Gansow, O1
Pippen, CG1
Raubitschek, A1
Mio, H1
Terabe, K1
Rustamov, IR1
Dzhulbekov, KI1
Gorbunov, GF1
Lu, J1
Zhao, L1
Liu, L1
Li, G1
Liu, F1
Asato, Y1
Yoshimi, F1
Ono, H1
Amemiya, R1
Koizumi, S1
Hasegawa, H1
Miya, T1
Goya, T1
Guillem, JG1
Puig-La Calle, J1
Akhurst, T1
Tickoo, S1
Ruo, L1
Minsky, BD1
Gollub, MJ1
Klimstra, DS1
Mazumdar, M1
Paty, PB1
Macapinlac, H1
Yeung, H1
Saltz, L1
Finn, RD1
Erdi, Y1
Humm, J1
Cohen, AM1
Larson, S1
Cantore, M1
Pederzoli, P1
Cornalba, G1
Fiorentini, G1
Guadagni, S1
Miserocchi, L1
Frassoldati, A1
Ceravolo, C1
Smerieri, F1
Muchmore, JH1
Swiatkowska-Freund, M1
Preis, K1
Emerich, J1
Yan, H1
Pestieau, SR1
Shmookler, BM1
Choi, SM1
Lee, SH1
Yang, YS1
Kim, BC1
Kim, MK1
Cho, KH1
Barth, G1
Basten, O1
Rüschoff, J1
Rompel, R1
Böhm, B1
Helfritzsch, H1
Thiele, M1
Altendorf-Hofmann, A1
Scheele, J1
Marchettini, P1
Shiian, DN2
Golden, GT1
Rosenthal, JD1
Shaw, A1
Fisher, B1
Glass, A1
Redmond, C1
Fisher, ER1
Barton, B1
Such, E1
Carbone, P1
Economou, S1
Foster, R1
Frelick, R1
Lerner, H1
Levitt, M1
Margolese, R1
MacFarlane, J1
Plotkin, D1
Shibata, H1
Volk, H1
Pratt, CB1
Rivera, G1
Shanks, E1
Johnson, WW1
Howarth, C1
Terrell, W1
Kumar, AP1
Kubota, T1
Shimosato, Y1
Nagai, K1
Jager, RM1
Max, MH1
Sasaki, T1
Ibuka, T1
Imai, K1
Monma, K1
Sakaki, N1
Tabata, I1
Ishiwata, J1
Onozawa, Y1
Ohno, T1
Wu, GR1
Nakamura, K1
Hihara, T1
Nishiumi, T1
Yoneyama, T1
Kiyabu, M1
Leichman, L1
Chandrasoma, P1
Niu, MY1
Sbalzarini, G1
Pandolfi, C1
Labadini, A1
Kanimoto, Y2
Suzuki, Y1
Miwa, Y1
Akino, H2
Isomatu, Y1
Kirita, T1
Ohchi, T1
Ihara, H1
Nishiyama, T1
Kon, M1
Imai, S1
Hamano, K1
Nishibuchi, S1
Hujita, T1
Isomatsu, Y1
Shiraishi, T1
Nakakuki, K1
Saito, D1
Yoshida, S1
Okazaki, N1
Ohkura, H1
Li, XT1
Kern, K1
Lack, E1
Kelly, R1
Ralston, M1
Penny, R1
Hayes, J1
Yamada, K1
Horiguchi, M1
Saito, A1
Sonoda, H1
Tsukiyama, I1
Akine, Y1
Kajiura, Y1
Ogino, T1
Yamashita, K1
Egawa, S1
Hijikata, J1
Kitagawa, T1
Pan, XY1
Li, FQ1
Yu, RJ1
Xie, GF1
Wang, H1
Zhao, LY1
Myoga, H1
Tamaki, M1
Shinko, Y1
Ohta, S1
Shigemasa, K1
Nogawa, T1
Katsube, Y1
Fujiwara, A1
San Martín, S1
Oddó, D1
Paredes, H1
Arraztoa, J1
Conte, PF1
Sertoli, MR1
Bruzzone, M1
Rubagotti, A1
Rosso, R1
Bentivoglio, G1
Conio, A1
Pescetto, G1
Barlow, JJ1
Lele, SB1
Emrich, LJ1
Sawada, M1
Hayakawa, M1
Morise, K1
Iizuka, A1
Inagaki, T1
Nakura, E1
Nishikawa, H1
Ohno, R1
Hayashi, N1
Tunekawa, H1
Kato, H1
Schneider, T1
Lotze, W1
Kasuga, Y1
Senga, O1
Hanamura, N1
Iida, F1
Oota, H1
Katsuyama, T1
Tsuchiya, S1
Maehara, Y1
Anai, H1
Kusumoto, H1
Sugimachi, K1
Saeed, W1
Kim, S1
Burch, BH1
Navashin, SM1
Fomina, IP1
Osokina, LI1
Zharikov, AA1
Smith, JP3
Rutledge, F2
Rottenberg, VI1
Knysh, VI1
Izsak, FC1
Eylan, E1
Gazith, A1
Shapiro, J1
Naharin, S1
Raanani, C1
Ferguson, E1
Obi, LJ1
Donaldson, MH1
Taylor, P1
Rawitscher, R1
Sewell, JB1
Speckhard, ME1
Hurley, JD1
Fetherston, WC1
Grueninger, AJ1
Wharton, JT1
Rutledge, FN1
Copeland, EM1
McBride, CM1
Ricci, JA1
Sanford, RG1
Brown, RB1
Silvernail, WI1
Baer, JW1
Gnatyshak, AI1
Aran, M1
Bilge, N1
Ozman, M1

Clinical Trials (11)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prospective Randomised Multicenter Phase-III-study: Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil Plus Oxaliplatin Versus Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil for Locally Advanced Rect[NCT00349076]Phase 31,256 participants (Actual)Interventional2006-07-31Completed
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)[NCT05913674]Phase 225 participants (Anticipated)Interventional2023-07-31Not yet recruiting
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Combination in Microsatellite Stable (MSS), MGMT Silenced Metastatic Colorectal Cancer (mCRC): the MAYA Study[NCT03832621]Phase 2135 participants (Actual)Interventional2019-03-25Completed
BEV-IP: Perioperative Chemotherapy With Bevacizumab in Patients Undergoing Cytoreduction and Intraperitoneal Chemoperfusion for Colorectal Carcinomatosis[NCT02399410]Phase 260 participants (Actual)Interventional2015-12-31Active, not recruiting
Total Neoadjuvant Therapy in Rectal Cancer Treatment[NCT04747951]Phase 4280 participants (Anticipated)Interventional2020-10-30Recruiting
Randomized Phase 2 Study Comparing Pathological Responses on Colorectal Cancer Metastases After Preoperative Treatment Combining Bevacizumab With FOLFOX or FOLFIRI[NCT01858649]Phase 260 participants (Actual)Interventional2013-05-31Completed
Randomised Phase 2 Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors[NCT01858662]Phase 24 participants (Actual)Interventional2014-01-31Terminated (stopped due to due to poor recrutment)
Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC II-IV, With a 5-FU-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.[NCT03034473]200 participants (Actual)Interventional2011-08-31Active, not recruiting
Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy[NCT00855946]46 participants (Actual)Observational2009-05-31Completed
KCSP Trial of cONsolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After neoadjUvant Concurrent chemoraDiothErapy: A Multicenter, Randomized Controlled Trial (KONCLUDE Trial)[NCT02843191]Phase 3358 participants (Anticipated)Interventional2016-12-31Recruiting
Prospective Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Multimodality Management of Locally Advanced Primary Rectal Cancer[NCT00004891]149 participants (Actual)Interventional1999-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

7 reviews available for fluorouracil and Carcinoma, Colloid

ArticleYear
[A case of mucinous adenocarcinoma of the sigmoid colon with disseminated carcinomatosis of the bone marrow successfully treated with FOLFOX4/bevacizumab].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:8

    Topics: Adenocarcinoma, Mucinous; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemother

2013
[Peritoneal tumor pathology - case no. 6: major histologic colloid response of colorectal peritoneal carcinomatosis after induction treatment].
    Annales de pathologie, 2015, Volume: 35, Issue:4

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Colonic Neoplas

2015
Synchronous quintuple primary gastrointestinal tract malignancies: Case report.
    World journal of gastroenterology, 2017, Jan-07, Volume: 23, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cancer

2017
[A Case of Intussusception Caused by Descending Colon Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Desce

2016
A novel K-ras mutation in colorectal cancer. A case report and literature review.
    Anticancer research, 2009, Volume: 29, Issue:8

    Topics: Adenocarcinoma, Mucinous; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineop

2009
Mucinous adenocarcinoma of the small bowel with peritoneal seeding.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2002, Volume: 28, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol

2002
[A case of primary signet ring cell carcinoma of the bladder].
    Hinyokika kiyo. Acta urologica Japonica, 1990, Volume: 36, Issue:4

    Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined

1990

Trials

29 trials available for fluorouracil and Carcinoma, Colloid

ArticleYear
Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial.
    JAMA network open, 2023, 06-01, Volume: 6, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Aged, 80 and over; Appendiceal Neoplasms; Colorectal

2023
Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.
    American journal of clinical oncology, 2020, Volume: 43, Issue:1

    Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cetuxim

2020
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial.
    European journal of cancer (Oxford, England : 1990), 2021, Volume: 144

    Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ri

2021
Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2013
Prospective phase II trial of second-line FOLFIRI in patients with advanced colorectal cancer including analysis of UGT1A1 polymorphisms: FLIGHT 2 study.
    Anticancer research, 2014, Volume: 34, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2014
Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2015
Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:20

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2014
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antige

2008
[Preliminary study of biweekly regimen of docetaxel, oxaliplatin, 5-fluorouracil and leucovorin for advanced gastric cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2008
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer.
    British journal of cancer, 2009, Jan-27, Volume: 100, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 8

2009
[Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2009
[Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:10

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclon

2010
Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution.
    Neoplasma, 2012, Volume: 59, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2012
The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Annals of surgical oncology, 2012, Volume: 19, Issue:7

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy,

2012
Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:8

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Colorecta

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
    The British journal of surgery, 2006, Volume: 93, Issue:10

    Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplas

2006
A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer.
    Oncology, 2007, Volume: 73, Issue:1-2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplast

2007
[Treatment of advanced ovarian cancer as an interdisciplinary task: surgery, histopathology, radiotherapy, and chemotherapy].
    Wiener klinische Wochenschrift, 1983, Jan-21, Volume: 95, Issue:2

    Topics: Adenocarcinoma, Mucinous; Bleomycin; Bone and Bones; Carcinoma; Chlorambucil; Cyclophosphamide; Doxo

1983
Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF).
    Cancer, 1981, Nov-01, Volume: 48, Issue:9

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma; Clinical Trial

1981
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Annals of surgery, 1995, Volume: 221, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Appendicea

1995
[Preoperative radiochemotherapy in primary non-resectable rectal cancer].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1995, Volume: 171, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Chemotherapy, Adjuvant; Female; Fluorouracil;

1995
[Preoperative intraluminal 5-FU osmosis chemotherapy as an adjuvant to radical resection for rectal cancer].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1996, Volume: 34, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy

1996
[Influence of preoperative on gastric cancer tissues and cells].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1997, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

1997
[Treatment for advanced colorectal carcinoma with 5-fluorouracil plus low-dose leucovorin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone

1999
Intra-arterial chemotherapy for unresectable pancreatic cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2000
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).
    Cancer, 1977, Volume: 39, Issue:6 Suppl

    Topics: Adenocarcinoma, Mucinous; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Clinical Trials

1977
[Reevaluation of intraluminal fluorouracil chemotherapy as an adjuvant to radical resection of colorectal cancer--results of a randomized trial].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1988, Volume: 10, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Colonic Neoplasms; Combined Modality Therapy;

1988
Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection.
    American journal of obstetrics and gynecology, 1985, Jun-01, Volume: 152, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

1985

Other Studies

149 other studies available for fluorouracil and Carcinoma, Colloid

ArticleYear
[A case of pembrolizumab responding to recurrent small bowel mucinous adenocarcinoma with Peutz-Jeghers syndrome].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2021, Volume: 118, Issue:11

    Topics: Adenocarcinoma, Mucinous; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pr

2021
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
    Journal of cancer research and clinical oncology, 2020, Volume: 146, Issue:2

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

2020
Impact of adjuvant chemotherapy on outcomes in appendiceal cancer.
    Cancer medicine, 2020, Volume: 9, Issue:10

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2020
Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG.
    Surgical oncology, 2020, Volume: 33

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antineoplastic Agents, Immunological; Antineoplastic Combi

2020
Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:12

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Administration, Intravenous; Adolescent; Adult; Aged; Aged

2020
Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.
    Diseases of the colon and rectum, 2018, Volume: 61, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colec

2018
Indolent Nodal Relapse of Colon Carcinoma with Associated Tumor Thrombus Invading the Superior Mesenteric Vein.
    Journal of gastrointestinal cancer, 2019, Volume: 50, Issue:3

    Topics: Adenocarcinoma, Mucinous; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Camptothec

2019
Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2018, Volume: 44, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Carcinoma, Signet Ring

2018
Skin Disorders and Primary Tumor Location as Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated with Cetuximab and Chemotherapy
    Asian Pacific journal of cancer prevention : APJCP, 2018, Aug-24, Volume: 19, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Cetuximab;

2018
Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
    BMC cancer, 2019, May-06, Volume: 19, Issue:1

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, T

2019
Conversion Surgery for Metastatic Pancreatic Mucinous Carcinoma Responsive to Systemic Chemotherapy with Modified FOLFIRINOX: A Case Report.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2019, Dec-03, Volume: 86, Issue:5

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Endoscopic Ultrasound-Guid

2019
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
    Diagnostic pathology, 2013, Feb-22, Volume: 8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarke

2013
Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.
    British journal of cancer, 2013, May-28, Volume: 108, Issue:10

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

2013
Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer.
    Annals of surgical oncology, 2014, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Cell Proli

2014
Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
    Annals of surgical oncology, 2013, Volume: 20, Issue:11

    Topics: Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot

2013
Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:11

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Chemotherapy, Adjuvant; Colorectal Neoplasms;

2013
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil.
    Anticancer research, 2013, Volume: 33, Issue:10

    Topics: Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Case-Control Stu

2013
Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma?
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:9

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine

2013
C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Anticancer research, 2013, Volume: 33, Issue:11

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

2013
[Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cel

2013
KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX.
    Annals of surgical oncology, 2015, Volume: 22, Issue:1

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

2015
Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 112, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineopl

2014
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
    Annals of surgical oncology, 2015, Volume: 22, Issue:8

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N

2015
Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:5

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Ch

2015
T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
    World journal of surgical oncology, 2015, Feb-19, Volume: 13

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carci

2015
Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
    American journal of surgery, 2015, Volume: 210, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2015
Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:14

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2015
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report.
    BMC cancer, 2015, Nov-10, Volume: 15

    Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capeci

2015
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Azacitidine; Carcinoma, Ductal, Breast; Carcinoma,

2016
Management of an inguinal hernia in patients with pseudomyxoma peritonei.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2017, Volume: 43, Issue:6

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N

2017
[A Case of Mucinous Adenocarcinoma of the Appendix with Peritoneal Dissemination Diagnosed by Laparoscopic Abdominal Exploration and Appendectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal

2016
A case of cardiogenic shock caused by capecitabine treatment.
    Nature clinical practice. Cardiovascular medicine, 2008, Volume: 5, Issue:11

    Topics: Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Appendiceal Neoplasms; Biomarkers; Biopsy

2008
Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).
    World journal of surgical oncology, 2008, Nov-11, Volume: 6

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Che

2008
Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
    Cancer science, 2009, Volume: 100, Issue:3

    Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western

2009
Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.
    International journal of radiation oncology, biology, physics, 2009, Sep-01, Volume: 75, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carc

2009
Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
    Annals of surgery, 2009, Volume: 249, Issue:4

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Appendectomy; Append

2009
Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix.
    Canadian journal of surgery. Journal canadien de chirurgie, 2009, Volume: 52, Issue:2

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Appendiceal Neoplasms; Camptothecin; C

2009
[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2009
[Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Age Factors; Aged; Antineoplastic Combined Chemothe

2009
Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
    International journal of radiation oncology, biology, physics, 2010, Mar-01, Volume: 76, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Ant

2010
Vulvar mucinous adenocarcinoma associated with Crohn's disease: report of two cases.
    Gynecologic and obstetric investigation, 2009, Volume: 68, Issue:4

    Topics: Adenocarcinoma, Mucinous; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineop

2009
Successful treatment of metastatic pancreatic adenocarcinoma with combination chemotherapy regimens.
    International journal of clinical oncology, 2009, Volume: 14, Issue:5

    Topics: Adenocarcinoma, Mucinous; Adult; Albumins; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized

2009
Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2010, Volume: 42, Issue:1

    Topics: Abdomen, Acute; Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bio

2010
[Assessment of chemoradiation therapy for advanced rectal cancer invaded the pelvic organ].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Adenocarcinoma, Mucinous; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modalit

2009
[Clinical features of hypersensitivity reactions to oxaliplatin among Chinese colorectal cancer patients].
    Chinese journal of cancer, 2010, Volume: 29, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Anaphylaxis; Anti-Allergic Agents

2010
[A case of postoperative liver metastasis of mucinous carcinoma of the breast with complete response to sequential administration of FEC75, tamoxifen citrate, and letrozole].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:3

    Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents,

2010
Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin.
    Journal of surgical oncology, 2010, Nov-01, Volume: 102, Issue:6

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Com

2010
Metastatic lymph node targeted chemosensitivity test for gastric cancer.
    The Journal of surgical research, 2011, Volume: 171, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; An

2011
[Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2010
Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
    International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma

2012
Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis.
    Annals of surgical oncology, 2011, Volume: 18, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2011
Real-world impact of availability of adjuvant therapy on outcomes in patients with resected pancreatic adenocarcinoma: a Canadian Cancer Agency experience.
    American journal of clinical oncology, 2012, Volume: 35, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Aged, 80 and over; Antineoplastic Combined Chemother

2012
Full-dose capecitabine with local radiotherapy: one of the treatment options for inoperable T4 breast cancer.
    Japanese journal of radiology, 2011, Volume: 29, Issue:3

    Topics: Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Chemother

2011
Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience.
    American journal of clinical oncology, 2012, Volume: 35, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Chemoradiotherapy, Adj

2012
Primary mucinous adenocarcinoma of the bladder: complete response with FOLFOX-4 regimen.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:3

    Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans

2012
Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer.
    Anticancer research, 2011, Volume: 31, Issue:11

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carc

2011
The role of chemoradiotherapy in patients with unresectable T4 breast tumors.
    Breast cancer (Tokyo, Japan), 2013, Volume: 20, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

2013
[Role of pharmacokinetic monitoring of serum fluorouracil concentration in patients with local advanced and metastatic colorectal cancer and further improving efficacy of fluorouracil-based chemotherapy].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2012
The use of Fluorouracil (5-FU) and leucovorin in women with heavily pretreated advanced ovarian carcinoma.
    American journal of clinical oncology, 2013, Volume: 36, Issue:5

    Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary

2013
[A case report of advanced mucinous adenocarcinoma of the transverse colon with peritoneal dissemination effectively treated by multidisciplinary approach with a focus on FOLFOX4 therapy combined with panitumumab].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:7

    Topics: Adenocarcinoma, Mucinous; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Co

2012
Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
    International journal of cancer, 2013, May-01, Volume: 132, Issue:9

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2013
Mucinous histology of colon cancer predicts poor outcomes with FOLFOX regimen in metastatic colon cancer.
    Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:4

    Topics: Activities of Daily Living; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Antineopla

2012
Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:8

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasm

2012
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
    International journal of oncology, 2013, Volume: 42, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Blotting, Western;

2013
[Clinicopathological features and prognosis of primary appendiceal adenocarcinoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2012
Sudden improvement of respiratory failure in a woman with carcinoma of the colon.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2002, Volume: 57, Issue:1

    Topics: Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Bronchial Neoplasms; Colonic Neopla

2002
Raltitrexed (Tomudex): an alternative choice in patients intolerant to 5-fluorouracil.
    Cancer investigation, 2002, Volume: 20, Issue:7-8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Colonic Diseases; D

2002
Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
    Cytokine, 2002, Nov-24, Volume: 20, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2002
Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination.
    Journal of surgical oncology, 2003, Volume: 83, Issue:1

    Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplas

2003
Presentations from the Walter Reed Army Medical Center. Case 1: rectal carcinoma.
    Oncology (Williston Park, N.Y.), 2003, Volume: 17, Issue:11

    Topics: Adenocarcinoma, Mucinous; Adult; Camptothecin; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; N

2003
Unusual abdominal tumors, case 1. Pseudomyxoma peritonei: response to capecitabine.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Apr-15, Volume: 22, Issue:8

    Topics: Abdominal Neoplasms; Adenocarcinoma, Mucinous; Appendiceal Neoplasms; Capecitabine; Deoxycytidine; F

2004
Mucinous and immunohistochemical changes of colonic adenocarcinoma secondary to chemo-radiotherapy.
    Histopathology, 2004, Volume: 45, Issue:1

    Topics: Adenocarcinoma, Mucinous; Aged; Carcinoembryonic Antigen; Colonic Neoplasms; Female; Fluorouracil; H

2004
S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study.
    Japanese journal of clinical oncology, 2004, Volume: 34, Issue:5

    Topics: Adenocarcinoma, Mucinous; Administration, Oral; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv

2004
Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.
    Oncology reports, 2004, Volume: 12, Issue:5

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

2004
Unfavourable expression of pharmacologic markers in mucinous colorectal cancer.
    British journal of cancer, 2005, Jan-31, Volume: 92, Issue:2

    Topics: Adenocarcinoma, Mucinous; Aged; Biomarkers, Tumor; Camptothecin; Colorectal Neoplasms; Disease-Free

2005
Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy.
    Journal of surgical oncology, 2005, Jul-01, Volume: 91, Issue:1

    Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplas

2005
Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Japanese journal of clinical oncology, 2005, Volume: 35, Issue:9

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2005
Microsatellite instability and colorectal cancer prognosis.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Dec-01, Volume: 11, Issue:23

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenocarcinoma, Mucinous; Antimetabolites, Ant

2005
A case of mucinous carcinoma of the breast that demonstrated a good pathological response to neoadjuvant chemotherapy despite a poor clinical response.
    Breast cancer (Tokyo, Japan), 2006, Volume: 13, Issue:1

    Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bre

2006
Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
    Annals of surgical oncology, 2006, Volume: 13, Issue:5

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N

2006
[Mucinous adenocarcinoma on chronic perianal fistula treated by neoadjuvant chemoradiotherapy and laparoscopy-assisted abdominoperineal amputation].
    Cirugia espanola, 2006, Volume: 79, Issue:3

    Topics: Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Anus Neoplasms; Chemotherapy, Adjuvant; C

2006
[Clinical observation on treatment of gastric cancer with zhijing granules: a report of 148 cases].
    Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2006, Volume: 4, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Dru

2006
Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Annals of surgical oncology, 2007, Volume: 14, Issue:8

    Topics: Adenocarcinoma, Mucinous; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Appen

2007
Establishment and characterization of an IGSK-2 cell line derived from ascitic fluid of recurrent hCG and somatostatin secreted adenocarcinoma of the stomach.
    Human cell, 2007, Volume: 20, Issue:2

    Topics: Adenocarcinoma, Mucinous; Adult; Animals; Antigens, Tumor-Associated, Carbohydrate; Ascitic Fluid; B

2007
Expression of orotate phosphoribosyl transferase in human pancreatic cancer: implication for the efficacy of uracil and tegafur-based adjuvant chemotherapy.
    Oncology reports, 2007, Volume: 18, Issue:1

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

2007
Isolated splenic metastasis from colorectal mucinous carcinoma.
    International journal of gastrointestinal cancer, 2006, Volume: 37, Issue:2-3

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Co

2006
Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
    Diseases of the colon and rectum, 2007, Volume: 50, Issue:10

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemother

2007
Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Mar-01, Volume: 14, Issue:5

    Topics: Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cohort Stud

2008
[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:11

    Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antineoplastic; Antim

2007
The treatment of 48 patients affected by ovarian carcinoma at stages III and IV F.I.G.O.
    European journal of gynaecological oncology, 1981, Volume: 2, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Cyclophosphamide; Cystadenocarcinoma; Female; Fluorouracil; H

1981
Clinical evaluation of preoperative combined chemotherapy with neocarzinostatin (NCS) and 5-Fluorouracil (combined NF therapy) against gastric cancer.
    Bulletin of the Osaka Medical School, 1981, Volume: 27, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antin

1981
Multimodality treatment of adenocarcinoma of the vagina Stage IV: potential for cure.
    Gynecologic oncology, 1983, Volume: 16, Issue:2

    Topics: Adenocarcinoma, Mucinous; Adult; Combined Modality Therapy; Female; Fluorouracil; Humans; Lymphatic

1983
Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Henry Ford Hospital medical journal, 1983, Volume: 31, Issue:2

    Topics: Adenocarcinoma, Mucinous; Aged; Colonic Neoplasms; Fluorouracil; Hemolytic-Uremic Syndrome; Humans;

1983
Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts.
    Oncology, 1984, Volume: 41, Issue:3

    Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Coloni

1984
Continuous infusion chemotherapy as a radiation-enhancing agent for yttrium-90-radiolabeled monoclonal antibody therapy of a human tumor xenograft.
    Gynecologic oncology, 1994, Volume: 55, Issue:1

    Topics: Adenocarcinoma, Mucinous; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Fluorouracil; Humans;

1994
[Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:4

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cel

1994
[Local use of a drug combination consisting of fluorouracil, cyclophosphamide and silicone sorbent in patients with colonic cancer].
    Klinicheskaia khirurgiia, 1993, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Administration, Topical; Antineoplastic Combined Chemother

1993
[Association of cancer and non-Hodgkin's lymphoma of the stomach].
    Klinichna khirurhiia, 1996, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplast

1996
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography.
    Diseases of the colon and rectum, 2000, Volume: 43, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Fluorodeoxyglucose F18; Fluorouracil; Gly

2000
[Appendiceal mucinous carcinoma].
    Ginekologia polska, 2000, Volume: 71, Issue:10

    Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplas

2000
Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2001, Volume: 14, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic;

2001
5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.
    Journal of Korean medical science, 2001, Volume: 16, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Brain; Breast Neop

2001
[Clinical and histopathological characteristics of early Leser-Trélat syndrome].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:7

    Topics: Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Colon; Colonic Neoplasms; Colonosco

2001
Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients.
    Annals of surgery, 2001, Volume: 234, Issue:2

    Topics: Adenocarcinoma, Mucinous; Appendiceal Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy;

2001
[Therapy results of locoregional recurrences in rectal cancer].
    Zentralblatt fur Chirurgie, 2001, Volume: 126, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Combined Modality Therapy

2001
[Determination of individual sensitivity of gastric cancer to 5-fluorouracil by tumor tissue respiratory and glycolytic indices].
    Voprosy onkologii, 1975, Volume: 21, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Scirrhous; Carcinoma; Fluorouracil; Glycol

1975
Carcinoma of the rectum in adolescence.
    American journal of diseases of children (1960), 1975, Volume: 129, Issue:6

    Topics: Adenocarcinoma, Mucinous; Adolescent; Age Factors; Cyclophosphamide; Fluorouracil; Humans; Hydroneph

1975
Colorectal carcinoma in adolescents implications regarding etiology.
    Cancer, 1977, Volume: 40, Issue:5 Suppl

    Topics: Adenocarcinoma, Mucinous; Adolescent; Adult; Child; Colonic Neoplasms; Female; Fluorouracil; Humans;

1977
Experimental chemotherapy of carcinoma of the human stomach and colon serially transplanted in nude mice.
    Gan, 1978, Volume: 69, Issue:3

    Topics: Adenocarcinoma, Mucinous; Animals; Colonic Neoplasms; Female; Fluorouracil; Humans; Mice; Mice, Nude

1978
Umbilical metastasis as the presenting symptom of cecal carcinoma.
    Journal of surgical oncology, 1979, Volume: 12, Issue:1

    Topics: Adenocarcinoma, Mucinous; Cecal Neoplasms; Female; Fluorouracil; Humans; Middle Aged; Umbilicus

1979
[Sequential MTX and 5-FU therapy of gastric cancer with systemic bone metastasis and disseminated intravascular coagulation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

1992
[Preoperative regional radiofrequency thermochemotherapy of colorectal cancer: clinical and pathological studies].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1992, Volume: 30, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Chemotherapy, Adjuvant; Colorectal Neoplasms; Diathermy; F

1992
[A case of metastatic urinary bladder tumor from gastric carcinoma].
    Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:7

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorouracil;

1992
Effects of preoperative chemotherapy on gastric adenocarcinomas. A morphologic study of 25 cases.
    Cancer, 1992, Nov-01, Volume: 70, Issue:9

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

1992
[Effect of combined use of chemotherapeutic agents and hematopor--phyrin derivative (HPD) on human gastric cancer cell line in vitro].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1992, Volume: 14, Issue:1

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Drug Synergism; Fluorouracil; Hematoporphyrin Deriv

1992
[Platelet aggregation during adjuvant chemotherapy with CMF].
    Minerva medica, 1991, Volume: 82, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

1991
[Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
    Hinyokika kiyo. Acta urologica Japonica, 1991, Volume: 37, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

1991
[Clinical evaluation of intra-arterial infusion of hyperthermo-chemotherapy in gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:11

    Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined

1991
[Effect of human epidermal factor (hEGF) on antitumor activity of 5-fluorouracil (5-FU) in human gastric cancer cell lines].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Cell Division; Cell Line; Cell Survival; Drug Screening As

1989
[Chemosensitivity of MGc 80-3 human gastric adenocarcinoma cells and its clinical significance].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1989, Volume: 11, Issue:5

    Topics: Adenocarcinoma, Mucinous; Amdinocillin; Antineoplastic Agents; Drug Screening Assays, Antitumor; Flu

1989
Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment.
    Diseases of the colon and rectum, 1987, Volume: 30, Issue:10

    Topics: Adenocarcinoma, Mucinous; Adult; Colonic Neoplasms; Combined Modality Therapy; Drug Therapy, Combina

1987
Chemotherapy influencing the course of nephrotic syndrome in colonic carcinoma.
    Medical oncology and tumor pharmacotherapy, 1987, Volume: 4, Issue:2

    Topics: Adenocarcinoma, Mucinous; Biopsy; Colonic Neoplasms; Fluorouracil; Glomerulonephritis; Humans; Immun

1987
Biological features and chemosensitivity of human colorectal cancer xenografted in nude mice.
    Gastroenterologia Japonica, 1987, Volume: 22, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Animals; Antineoplastic Agents; Carcinoembryonic Antigen;

1987
[A gastric cancer showing marked improvement (stage IV) with lentinan immunotherapy and 5-FU, MMC-chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:6

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Gastroscopy;

1988
Radiation therapy for advanced gastric cancer.
    International journal of radiation oncology, biology, physics, 1988, Volume: 15, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over;

1988
[Experimental chemotherapy of human gastric cancer cell lines in vitro and in nude mice].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1988, Volume: 10, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Allyl Compounds; Animals; Antibiotics, Antineoplastic; Cel

1988
[Synchronous double cancers in the ovary and kidney--a case report].
    Gan no rinsho. Japan journal of cancer clinics, 1988, Volume: 34, Issue:14

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Com

1988
[Signet ring cell carcinoma of the colon].
    Revista medica de Chile, 1988, Volume: 116, Issue:7

    Topics: Adenocarcinoma, Mucinous; Adult; Colonic Neoplasms; Female; Fluorouracil; Humans; Postoperative Care

1988
Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer.
    Gynecologic oncology, 1985, Volume: 20, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

1985
[Experimental chemotherapy of ovarian cancers heterotransplanted in nude mice].
    Nihon Sanka Fujinka Gakkai zasshi, 1985, Volume: 37, Issue:8

    Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto

1985
[Sequential chemotherapy with low-dose methotrexate and 5-fluorouracil in advanced gastric cancer].
    Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:10

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

1985
[Cytostatic treatment of pseudomyxoma peritonei].
    Zentralblatt fur Gynakologie, 1985, Volume: 107, Issue:24

    Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; F

1985
[A case of bilateral metastatic breast carcinoma from gastric carcinoma].
    Gan no rinsho. Japan journal of cancer clinics, 1986, Volume: 32, Issue:4

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined

1986
Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1987, Volume: 13, Issue:3

    Topics: Aclarubicin; Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Age

1987
Development of carcinoma in regional enteritis.
    Archives of surgery (Chicago, Ill. : 1960), 1974, Volume: 108, Issue:3

    Topics: Adenocarcinoma, Mucinous; Barium Sulfate; Cecum; Colon; Colonic Diseases; Crohn Disease; Enema; Fluo

1974
[Study of the action of antitumor compounds on primary explants from human tumors].
    Antibiotiki, 1967, Volume: 12, Issue:9

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Scirrhous; Antibiotics, Antineoplastic; An

1967
Chemotherapy in the treatment of cancer of the ovary.
    American journal of obstetrics and gynecology, 1970, Jul-01, Volume: 107, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Cyclophosphamide; Cystadenocarcinoma; Dactinomycin; Female

1970
[Pathologic anatomy of rectal cancer treated by intra-arterial administration of 5-fluoruracil].
    Arkhiv patologii, 1970, Volume: 32, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Female;

1970
Growth inhibiting effects of cytotoxic agents on human tumor and tumor-bearing normal tissue in vitro.
    European journal of cancer, 1971, Volume: 7, Issue:1

    Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Intra

1971
Carcinoma of the colon and rectum in patients up to 25 years of age.
    The American surgeon, 1971, Volume: 37, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adolescent; Adult; Age Factors; Colonic Neoplasms; Female;

1971
Colon carcinoma in childhood.
    Pediatrics, 1971, Volume: 48, Issue:2

    Topics: Adenocarcinoma, Mucinous; Adolescent; Age Factors; Barium Sulfate; Child; Colonic Neoplasms; Female;

1971
Integrated therapy in the treatment of ovarian cancer with surgery, radiation and chemotherapy.
    Oncology, 1972, Volume: 26, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Ascites; Chlorambucil; Cobalt Isotopes; Cyclophosphamide;

1972
Chemotherapy of ovarian cancer. New approaches to treatment.
    Cancer, 1972, Volume: 30, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antineoplastic Agents; Cyclophosphamide; Cystadenocarcinom

1972
Metastatic ovarian cancer.
    Clinical obstetrics and gynecology, 1973, Volume: 16, Issue:2

    Topics: Adenocarcinoma, Mucinous; Cyclophosphamide; Cystadenocarcinoma; Dactinomycin; Drug Combinations; Fem

1973
Axillary metastases from unknown primary sites.
    Annals of surgery, 1973, Volume: 178, Issue:1

    Topics: Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Squamous Cel

1973
Long term survivor in metastatic colonic carcinoma to the brain.
    Pennsylvania medicine, 1973, Volume: 76, Issue:10

    Topics: Adenocarcinoma, Mucinous; Brain Neoplasms; Colonic Neoplasms; Fluorouracil; Humans; Male; Middle Age

1973
An unusual case of adenocarcinoma of the pancreas.
    The American journal of digestive diseases, 1974, Volume: 19, Issue:7

    Topics: Adenocarcinoma, Mucinous; Adult; Antibiotics, Antineoplastic; Aorta, Abdominal; Calcinosis; Cystaden

1974
[Determination of the individual sensitivity of gastric cancerous tumors to 5-fluorouracil according to respiratory and glycolytic indices].
    Vrachebnoe delo, 1974, Volume: 5, Issue:0

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Scirrhous; Carcinoma; Drug Evaluation, Pre

1974
[5-Fluorouracil in the treatment of gastrointestinal tumors].
    Turk Tip Dernegi dergisi, 1973, Volume: 39, Issue:12

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Fluorouracil; Gastrointestinal Neoplasms; Humans

1973